FDX1作为预后生物标志物,通过调节免疫反应来促进质瘤的进展

Guangying Zhang1, Liangfang Shen2, Zhanzhan Li2

  • 1Department of Infectious Diseases, Hunan Key Laboratory of Viral Hepatitis, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, P.R. China.

Aging
|June 10, 2023
PubMed
概括

高FDX1基因表达与质瘤预后不佳相关,并影响免疫细胞透. 准FDX1可能会提高质瘤免疫治疗的有效性.